速效救心丸通过ALKBH5/GSK3β/mTOR通路减轻心肌缺血再灌注损伤
本研究在大鼠心肌缺血再灌注损伤(MIRI)模型及缺氧/复氧(H/R)H9c2细胞中探究速效救心丸(SJP)的作用机制。SJP可减小梗死面积、减少心肌凋亡并改善左心室功能,通过ALKBH5/GSK3β/mTOR通路抑制自噬和凋亡,其作用与主要成分四甲基吡嗪(TMP)和冰片(BOR)相关。
要点
- SJP减轻大鼠MIRI,减小梗死面积、减少凋亡、改善左心室功能。
- SJP通过ALKBH5/GSK3β/mTOR通路抑制H/R心肌细胞自噬与凋亡。
- TMP和BOR是SJP上述保护作用的共同主要成分。
核心结论
- SJP通过ALKBH5/GSK3β/mTOR通路改善大鼠MIRI并减轻H9c2细胞自噬与凋亡。
- 该作用归因于SJP的两种主要成分TMP和BOR。
研究设计与样本
- 体内实验采用Wistar大鼠MIRI模型,体外采用缺氧/复氧处理的H9c2细胞。
- 通过慢病毒转染构建ALKBH5和GSK3β沉默的H9c2细胞。
主要发现
- SJP显著减轻大鼠MIRI,减小梗死面积和心肌凋亡,改善左心室功能。
- SJP通过GSK3β/mTOR通路抑制MIRI大鼠自噬。
- SJP增强H/R心肌细胞ALKBH5表达,ALKBH5敲低增强自噬和凋亡,SJP可逆转。
- ALKBH5缺失增强的自噬和凋亡依赖GSK3β/mTOR通路,SJP给药后减轻。
临床怎么用
- 为SJP用于MIRI提供ALKBH5/GSK3β/mTOR通路的机制证据,支持其临床潜在应用。
局限性
- 机制结论主要来自动物模型和细胞实验,尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Many studies have shown effective protection from myocardial ischemia-reperfusion injury (MIRI) in animal models, but few, if any, treatments have yielded a substantial reduction in clinical. Several studies showed significant therapeutic effects for the Chinese patent medicine Suxiao Jiuxin Pill (SJP) in MIRI, although the specific molecular mechanisms remain undefined. Recently, increasing evidence indicates an important role for m6A modification in autophagy regulation in MIRI, and SJP has not been investigated in this regard. METHODS: In vivo experiments were performed in a Wistar rat MIRI model. In vitro assays were conducted in hypoxia/reoxygenation (H/R)-treated H9c2 cells. H9c2 cells with ALKBH5 and GSK3β silencing were constructed by lentivirus transfection. TUNEL and Annexin V/PI assays were carried out for apoptosis detection. Then, m6A modification was detected with the EpiQuik m6A RNA methylation quantification kit, and GFP-RFP-LC3B was used to observe dynamic changes in autophagy. The autophagosome structure was assessed by Transmission electron microscopy. qPCR and immunoblot were performed for mRNA and protein analyses, receptively. RESULTS: SJP significantly mitigated MIRI in rats, reducing infarct size and myocardial apoptosis, and improving left ventricular function. In addition, SJP inhibited autophagy through the GSK3β/mTOR pathway in MIRI rats. In cultured H9c2 cells, SJP significantly inhibited H/R- related apoptosis and autophagic activity through the GSK3β/mTOR pathway. Additionally, SJP enhanced ALKBH5 expression in H/R cardiomyocytes, which is important in impaired m6A modification. Interestingly, ALKBH5 knockdown enhanced autophagy and apoptosis in H/R-induced cells, whereas SJP reversed these effects. Further experiments showed that autophagic activity and apoptosis enhanced by ALKBH5 deficiency are GSK3β/mTOR pathway dependent in H/R-treated H9c2 cells. After SJP administration the above effects were alleviated, suggesting SJP inhibited autophagy through the ALKBH5/GSK3β/mTOR pathway in H/R-induced cardiomyocytes. These effects of SJP were common to its two main constituents, including tetra-methylpyrazine (TMP) and borneol (BOR). CONCLUSION: SJP improves MIRI in rats and alleviates autophagy and apoptosis in H9c2 cells through the ALKBH5/GSK3β/mTOR pathway, thanks to its two major constituents TMP and BOR.
引用
- Li Y, Lu R, Niu Z, et al. Suxiao Jiuxin Pill alleviates myocardial ischemia-reperfusion injury through the ALKBH5/GSK3β/mTOR pathway. Chin Med. 2023. PMID: 36959603. doi:10.1186/s13020-023-00736-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。